Successful methods of treating leg ulcers - The tried and true, plus the novel and new

被引:24
作者
Phillips, TJ [1 ]
机构
[1] Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA
关键词
D O I
10.3810/pgm.1999.05.1.744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cause of a leg ulcer should be determined before a course of treatment is undertaken, and this often can be accomplished through history taking, physical examination, and use of simple noninvasive testing. Most leg ulcers are caused by venous disease, arterial insufficiency, neuropathy, or a combination of these factors. Complete management should address the patient's general health as well as specific findings, and treatment of any underlying cause is paramount. In venous ulcers, compression is the cornerstone of treatment, and a variety of effective stockings and other compression devices are available. Arterial ulcers usually require reestablishment of an adequate vascular supply, often through surgery. Neuropathic ulcers need thorough debridement to allow good granulation and epithelialization. Five types of occlusive dressings are available that achieve debridement less painfully but also more slowly than the surgical approach. Several adjunctive methods are now available that facilitate successful therapy in these ulcers, which have often been considered non healing wounds.
引用
收藏
页码:159 / +
页数:9
相关论文
共 6 条
[1]   ASSESSMENT AND MANAGEMENT OF FOOT DISEASE IN PATIENTS WITH DIABETES [J].
CAPUTO, GM ;
CAVANAGH, PR ;
ULBRECHT, JS ;
GIBBONS, GW ;
KARCHMER, AW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (13) :854-860
[2]   VENOUS ULCERATION AND SAPHENOUS LIGATION [J].
DARKE, SG ;
PENFOLD, C .
EUROPEAN JOURNAL OF VASCULAR SURGERY, 1992, 6 (01) :4-9
[3]   Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent [J].
Falanga, V ;
Margolis, D ;
Alvarez, O ;
Auletta, M ;
Maggiacomo, F ;
Altman, M ;
Jensen, J ;
Sabolinski, M ;
Hardin-Young, J .
ARCHIVES OF DERMATOLOGY, 1998, 134 (03) :293-300
[4]   LEG ULCERS [J].
PHILLIPS, TJ ;
DOVER, JS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (06) :965-987
[5]  
Steed DL, 1996, J AM COLL SURGEONS, V183, P61
[6]   Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers - A phase III randomized placebo-controlled double-blind study [J].
Wieman, TJ ;
Smiell, JM ;
Su, YC .
DIABETES CARE, 1998, 21 (05) :822-827